Aptamer Based, Non-PCR, Non-Serological Detection of Chagas Disease Biomarkers in Trypanosoma cruzi Infected Mice

Comparing human pancreatic cell secretomes by in vitro aptamer selection identifies cyclophilin B as a candidate pancreatic cancer biomarker

(2012) Partha Ray et al.   JOURNAL OF CLINICAL INVESTIGATION

Proteomic Analysis of Trypanosoma cruzi Secretome: Characterization of Two Populations of Extracellular Vesicles and Soluble Proteins

(2012) Ethel Bayer-Santos et al.   JOURNAL OF PROTEOME RESEARCH

Serum Proteomic Signature of Human Chagasic Patients for the Identification of Novel Potential Protein Biomarkers of Disease

(2012) Jian-Jun Wen et al.   MOLECULAR & CELLULAR PROTEOMICS

Development of an Aptamer-Based Concentration Method for the Detection of Trypanosoma cruzi in Blood

(2012) Rana Nagarkatti et al.   PLoS One

Quantitative proteomics of Trypanosoma cruzi during metacyclogenesis

(2012) Lyris Martins Franco de Godoy et al.   PROTEOMICS

Update in treatment of Chagas disease

(2011) Guillaume Le Loup et al.   CURRENT OPINION IN INFECTIOUS DISEASES

Methodological advances in drug discovery for Chagas disease

(2011) Juan M Bustamante et al.   Expert Opinion on Drug Discovery

The use of IgG antibodies in conventional and non-conventional immunodiagnostic tests for early prognosis after treatment of Chagas disease

(2011) Ana Paula Barbosa Wendling et al.   JOURNAL OF IMMUNOLOGICAL METHODS

IL-10 Limits Parasite Burden and Protects against Fatal Myocarditis in a Mouse Model of Trypanosoma cruzi Infection

(2011) E. Roffe et al.   JOURNAL OF IMMUNOLOGY

Improved Proteomic Approach for the Discovery of Potential Vaccine Targets in Trypanosoma cruzi

(2011) Ernesto S. Nakayasu et al.   JOURNAL OF PROTEOME RESEARCH

Valuation of biomarkers

(2011) Orest Hurko et al.   NATURE REVIEWS DRUG DISCOVERY

Regulatory T Cells Phenotype in Different Clinical Forms of Chagas' Disease

(2011) Fernanda Fortes de Araújo et al.   PLoS Neglected Tropical Diseases

International Study to Evaluate PCR Methods for Detection of Trypanosoma cruzi DNA in Blood Samples from Chagas Disease Patients

(2011) Alejandro G. Schijman et al.   PLoS Neglected Tropical Diseases

Plasma biomarker discovery and validation for colorectal cancer by quantitative shotgun mass spectrometry and protein microarray

(2010) Yusuke Murakoshi et al.   CANCER SCIENCE

The urgent need to develop new drugs and tools for the treatment of Chagas disease

(2010) Maria J Muñoz et al.   Expert Review of Anti-Infective Therapy

Identification of Novel Diagnostic Serum Biomarkers for Chagas' Disease in Asymptomatic Subjects by Mass Spectrometric Profiling

(2010) M. Ndao et al.   JOURNAL OF CLINICAL MICROBIOLOGY

Circulating Cardiac Troponin-I Autoantibodies in Human Plasma and Serum

(2009) Maciej Adamczyk et al.   Annals of the New York Academy of Sciences

Aptamers generated by Cell SELEX for biomarker discovery

(2009) Youngmi Kim et al.   Biomarkers in Medicine

Disease-specific biomarker discovery by aptamers

(2009) Henning Ulrich et al.   CYTOMETRY PART A

Usefulness of PCR-based assays to assess drug efficacy in Chagas disease chemotherapy: value and limitations

(2009) Constança Carvalho Britto   MEMORIAS DO INSTITUTO OSWALDO CRUZ

Drug-induced cure drives conversion to a stable and protective CD8+ T central memory response in chronic Chagas disease

(2008) Juan M Bustamante et al.   NATURE MEDICINE

Strategic Approach to Fit-for-Purpose Biomarkers in Drug Development

(2007) John A. Wagner   Annual Review of Pharmacology and Toxicology

Conservation of the pro-apoptotic nuclease activity of endonuclease G in unicellular trypanosomatid parasites

(2007) S. Gannavaram et al.   JOURNAL OF CELL SCIENCE